All Regulation articles – Page 3
-
NewsNew protocol aims to improve detection of adulterated honey
Guidance for authenticity databases will aid detection of products bulked out with cheap sugar syrups
-
NewsCalifornia ban on four food additives could spur wider action across US
New law prohibiting brominated vegetable oil, potassium bromate, propylparaben and red dye 3 in food uses is effective January 2027
-
NewsEU’s carbon border tariff enters first phase
Carbon border adjustment mechanism aims to equalise the carbon price of domestic and imported products
-
BusinessChemours is responsible for PFAS pollution, Dutch court rules
Interim decision holds DuPont spin-off liable for environmental damage caused by historical emissions from Dordrecht plant
-
BusinessUS regulator says phenylephrine is ineffective as a decongestant
FDA will begin consultation on removing the drug from hundreds of over-the-counter remedies
-
BusinessAddressing the saga of nitrosamine contamination in drugs
Scientific and regulatory progress is helping minimise the impact of mutagenic impurities
-
BusinessTornado at Pfizer plant accentuates US drug shortage issues
Perennial problem will not be addressed without major reforms to drug market
-
BusinessLapsed US chemical security programme leaves facilities vulnerable
Chemical Facility Anti-Terrorism Standards’ expiry means rules will not be enforced, and companies cannot vet new staff
-
NewsEuropean intellectual property system ready for gene-edited crops
Updates to New Genomic Technology regulations irrelevant to IP say experts
-
OpinionResistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
-
NewsUS safety board warns of hurricane threat to chemical facilities
US Federal Energy Reculatory Commission overlooked hurricane threat in guidance governing transmission system planning requirements
-
NewsDispute over formaldehyde toxicity assessment escalates
US scientific academy finds EPA’s review linking formaldehyde to cancer is supported by evidence, chemical industry pushes back with lawsuit
-
BusinessFines upheld for Advanz Pharma over thyroid drug price increases
UK competition tribunal rules liothyronine pricing ’excessive’ and ‘deliberate’
-
NewsLow UK carbon prices ‘disincentivise’ investment in decarbonisation technology
Changes to the UK’s emissions trading scheme could damage the chances of reaching net zero
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
BusinessIllumina’s Grail quest results in epic fine
EU and US competition authorities object to firms completing merger without approval
-
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
BusinessRevolutionising RSV prevention
New vaccines and a long-acting antibody aim to protect older adults and babies from respiratory syncytial virus
-
BusinessEnvironmental groups claim US herbicide reapprovals were illegal
Lawsuit says Environmental Protection Agency ignored serious risks with 2,4-D-containing Enlist products
-
OpinionBringing drug manufacturing back home
Pharmaceutical supply chains are international, complex and opaque. Is there a better way?